Ardent Health (NYSE:ARDT) Releases FY 2025 Earnings Guidance

Ardent Health (NYSE:ARDT) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 0.850-1.030 for the period, compared to the consensus estimate of 1.850. The company issued revenue guidance of $6.2 billion-$6.5 billion, compared to the consensus revenue estimate of $6.3 billion.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the stock. Bank of America cut Ardent Health from a “neutral” rating to an “underperform” rating and cut their price objective for the company from $15.50 to $14.60 in a report on Wednesday, July 16th. KeyCorp cut their price target on shares of Ardent Health from $24.00 to $20.00 and set an “overweight” rating on the stock in a research note on Thursday, August 7th. Wall Street Zen raised shares of Ardent Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 9th. JPMorgan Chase & Co. dropped their price objective on shares of Ardent Health from $18.00 to $15.00 and set a “neutral” rating on the stock in a report on Monday, August 11th. Finally, Weiss Ratings raised shares of Ardent Health from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, October 24th. Eight research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $18.78.

Ardent Health Trading Up 0.3%

Shares of NYSE ARDT traded up $0.05 during trading on Wednesday, reaching $14.10. The company had a trading volume of 578,511 shares, compared to its average volume of 391,890. The stock has a market cap of $2.02 billion, a P/E ratio of 7.79, a PEG ratio of 6.04 and a beta of 0.44. The company’s fifty day moving average price is $13.93 and its 200-day moving average price is $13.39. The company has a quick ratio of 2.00, a current ratio of 2.13 and a debt-to-equity ratio of 0.66. Ardent Health has a 12 month low of $10.10 and a 12 month high of $17.95.

Ardent Health (NYSE:ARDT) last announced its quarterly earnings results on Wednesday, November 12th. The company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.10. Ardent Health had a return on equity of 16.66% and a net margin of 4.11%. Ardent Health has set its FY 2025 guidance at 0.850-1.030 EPS. As a group, research analysts expect that Ardent Health will post 1.23 earnings per share for the current year.

Institutional Trading of Ardent Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ARDT. New York State Common Retirement Fund boosted its stake in Ardent Health by 121.4% during the second quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock worth $85,000 after buying an additional 3,400 shares during the period. Marshall Wace LLP purchased a new position in Ardent Health during the second quarter valued at approximately $147,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Ardent Health by 103.8% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company’s stock worth $194,000 after buying an additional 7,182 shares during the period. Creative Planning bought a new stake in Ardent Health during the second quarter valued at about $216,000. Finally, WINTON GROUP Ltd bought a new stake in shares of Ardent Health in the 2nd quarter valued at about $228,000.

Ardent Health Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.